Skip to main content
. Author manuscript; available in PMC: 2021 May 12.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Jul 6;25(11):2267–2273. doi: 10.1016/j.bbmt.2019.07.001

Table 4.

GVHD Outcomes at Day 30, Day 100, and Year 1

Characteristic n (%)
Day 30
 GVHD (n = 38)
  No 27 (73.0)
  Yes 10 (27.0)
  Missing 1
 Grade (n = 10)
  Grade I 4 (40.0)
  Grade II 1 (10.0)
  Grade III 3 (30.0)
  Grade IV 2 (20.0)
Day 100
 GVHD (n = 33)
  No 22 (71.0)
  Yes 9 (29.0)
  Missing 2
 Grade (n = 9)
  Grade I (mild) 2 (25.0)
  Grade II (moderate) 4 (50.0)
  Grade III (severe) 1 (12.5)
  Grade IV (life-threatening) 1 (12.5)
  Missing 1
 Disease chronicity (n = 9)
  Acute 6 (85.7)
  Chronic 1 (14.3)
  Missing 2
Year 1
 GVHD (n = 26)
  No 15 (62.5)
  Yes 9 (37.5)
  Missing 2
 Grade (n = 9)
  Grade I (mild) 3 (33.3)
  Grade II (moderate) 1 (16.7)
  Grade III (severe) 3 (50.0)
  Missing 2
 Disease chronicity (n = 9)
  Acute 2 (25.0)
  Chronic 6 (75.0)
  Missing 1